“…Representation of the suggested fragmentation schemes (interlink as well as intralink cross-linked peptides) of DSS and DSSO cross-linked peptides. ( d ) In addition to DSS and DSSO, most commonly used cross-linkers are shown (SuDP, Disuccinimidylsuccinamyl aspartyl proline; DSBU, Disuccinimidyldibutyric urea; BS3, Bis(sulfosuccinimidyl) suberate; DC4, 1,4-Bis{4-[(2,5-dioxo-1-pyrrolidinyl) oxy]-4-oxobutyl}-1,4-diazoniabicyclo[2.2.2]octaneoctane; PAC4, 1,1-Bis{4-[(2,5-dioxopyrrolidin-1-yl)oxy]-4-oxobutyl}-4-ethynylpiperidin-1-ium; EDC, 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide; Azide-A-DSBSO, Azide-tagged, acid-cleavable disuccinimidyl bissulfoxide; SDA, succinimidyl 4,4’-azipentanoate; CBDPS, Cyanurbiotindipropionyl succinimide; and PIR, protein interaction reporter) [ 71 , 72 , 89 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 ]. ( e ) For the enrichment of cross-linked products/peptides a few specific cross-linkers areused such as:PhoX linker (non-cleavable but containing a phosphonic group) [ 101 ], CLIP cross-linker (introduces alkyne groups to cross-linked peptides) [ 102 ], and 13 C labeled form of biphenyldiglyoxal (diglyoxal cross-linkers) [ 103 , 104 ].…”